Regenn™ NPTS Clinical Safety Study Completes Patient Enrollment
Progenerative Medical is pleased to announce the enrollment completion of the clinical safety study for its Regenn™ Negative Pressure Therapy System (NPTS). CEO, Neal Vail, said, “This is a major milestone for us, putting us on track to complete the study later this year followed by submission of our FDA application". San Antonio, TX, USA. [...]
Stay In Touch